Geometry and charge determine pharmacological effects of steroids on N- methyl-D-aspartate receptor-induced Ca2+ accumulation and cell death

Journal of Pharmacology and Experimental Therapeutics

Volumn 293, Issue 3, 2000, Pages 747-754

  Weaver, Charles E ^a   Land, Michele B ^a   Purdy, Robert H ^a,b   Richards, Kyle G ^a   Gibbs, Terrell T ^a   Farb, David H ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID RECEPTOR; STEROID;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL DEATH; DRUG ACTIVITY; FETUS; GEOMETRY; HORMONE ACTION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOCHEMISTRY;

ANIMALS; CALCIUM; CELL DEATH; HIPPOCAMPUS; MOLECULAR CONFORMATION; N-METHYLASPARTATE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; STEROIDS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034089646     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Beckman JS, Beckman TW, Chen J, Marshall PA and Freeman BA (1990) Apparent radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620-1624.
2. Behl C, Widmann M, Trapp T and Holsboer F (1995) 17-b Estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 216:473-482.
3. Bowlby MR (1993) Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons. Mol Pharmacol 43:813-819.
4. Brewer GJ and Cotman CW (1989) Survival and growth of hippocampal neurons in defined medium at low density: Advantages of a sandwich culture technique or low oxygen. Brain Res 494:65-74.
5. Chan PH (1996) Role of oxidants in ischemic brain damage. Stroke 27:1124-1129.
6. Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634.
7. Choi DW (1992) Excitotoxic cell death. J Neurobiol 23:1261-1276.
8. Choi D, Koh J and Peters S (1988) Pharmacology of glutamate neurotoxicity in cortical cell culture: Attenuation by NMDA antagonists. J Neurosci 8:185-196.
9. Collingridge GL and Bliss TVP (1987) NMDA receptors - Their role in long-term potentiation. Trends Neurosci 10:288-293.
10. Corpéchot C, Synguelakis M, Talha S, Axelson M, Sjöval J, Vihko R, Baulieu E-E and Robel P (1983) Pregnenolone and its sulfate ester in the rat brain. Brain Res 270:119-125.
11. Dawson VL, Dawson TM, London ED, Bredt DS and Snyder SH (1991) Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA 88:6368-6371.
12. Farb DH and Gibbs TT (1996) Steroids as modulators of amino acid receptor function, in CNS Neurotransmitters and Neuromodulators: Neuroactive Steroids (Stone TW ed) pp 23-36, CRC Press, New York.
13. Farrant M and Webster RA (1989) GABA antagonists: Their use and mechanisms of action, in Drugs as Tools in Neurotransmitter Research (Boulton AA, Baker GB and Juorio AV eds) pp 161-219, Humana Press Inc., Clifton.
14. Flood JF, Morley JE and Roberts E (1995) Pregnenolone sulfate enhances post-training memory processes when injected in very low doses into limbic system structures: The amygdala is by far the most sensitive. Proc Natl Acad Sci USA 92:10806-10810.
15. Gómez-Pinilla F, Tram H, Cotman CW and Nieto-Saampedro M (1989) Neuroprotective effects of MK-801 and U-50488H after contusive spinal cord injury. Exp Neurol 104:118-124.
16. Greenamyre JT (1991) Neuronal bioenergetic defects, excitotoxicity and Alzheimer's disease: 'Use it and lose it'. Neurobiol Aging 12:334-336.
17. Greenamyre JT and O'Brien FC (1991) N-methyl-D-aspartate antagonists in the treatment of Parkinson's disease. Arch Neurol 48:977-981.
18. Greenamyre JT and Young AB (1989) Excitatory amino acids and Alzheimer's disease. Neurobiol Aging 10:593-602.
19. 2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J 281:627-630.
20. Honore T, Davies S, Drejer J, Fletcher E, Jacobsen P, Lodge D and Nielsen F (1988) Quinoxalinediones: Potent competitive non-NMDA glutamate receptor antagonists. Science (Wash DC) 84:8215-8219.
21. Isaacson RL, Yoder PE and Varner J (1994) The effects of pregnenolone on acquisi-tion and retention of a food search task. Behav Neurol Biol 61:170-176.
22. Joseph R, Li W and Han E (1993) Neuronal death, cytoplasmic calcium and internucleosomal DNA fragmentation: Evidence for DNA fragments being released from cells. Brain Res Mol Brain Res 17:70-76.
23. Koh J, Goldberg MP, Hartley DM and Choi DW (1990) Non-NMDA receptor-mediated neurotoxicity in cortical culture. J Neurosci 10:693-705.
24. Mac Dermott A, Mayer M, Westbrook G, Smith S and Barker J (1986) NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones. Nature (Lond) 361:65-90.
25. Miura T, Muraoka S and Ogiso T (1996) Inhibition of lipid peroxidation by estradiol and 2-hydroxyestradiol. Steroids 61:379-383.
26. Monyer H, Hartley DM and Choi DW (1990) 21-Aminosteroids attenuate excitotoxic neuronal injury in cortical cell cultures. Neuron 5:121-126.
27. Olney JW (1986) Inciting excitotoxic cytocide among central neurons. Adv Exp Med Biol 203:631-645.
28. Park-Chung M (1997) Steroids as Functional Modulators of Amino Acid Receptors. Thesis, Boston University School of Medicine, Department of Pharmacology and Experimental Therapeutics, Boston.
29. Park-Chung M, Wu F-S and Farb DH (1994) 3α-Hydroxy-5β-pregnan-20-one sulfate: A negative modulator of the NMDA-induced current in cultured neurons. Mol Pharmacol 46:146-150.
30. Park-Chung M, Wu F-S, Purdy RH, Malayev AA, Gibbs TT and Farb DH (1997) Distinct sites for inverse modulation of NMDA receptors by sulfated steroids. Mol Pharmacol 52:1113-1123.
31. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG and Cotman CW (1993) Neurodegeneration induced by beta-amyloid peptides in vitro: The role of peptide assembly state. J Neurosci 13:1676-1687.
32. Rami A, Ferger D and Krieglstein J (1997) Blockade of calpain proteolytic activity rescues neurons from glutamate excitotoxicity. Neurosci Res 27:93-97.
33. Rothman SM and Olney JW (1986) Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 19:105-111.
34. Siman R and Noszek JC (1988) Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo. Neuron 1:279-287.
35. Vallee M, Mayo W, Darnaudery M, Corpechot C, Young J, Koehl M, Le Moal M, Baulieu EE, Robel P and Simon H (1997) Neurosteroids: Deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus. Proc Natl Acad Sci USA 94:14865-14870.
36. Weaver CE, Marek P, Park-Chung M, Tam SW and Farb DH (1997a) Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA 94:10450-10454.
37. Weaver CE, Park-Chung M, Gibbs TT and Farb DH (1997b) 17b-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res 761:338-341.
38. Weaver CE Jr, Wu F-S, Gibbs TT and Farb DH (1998) Pregnenolone sulfate exacerbates NMDA-induced cell death of hippocampal neurons. Brain Res 803:129-136.
39. Wu F-S, Gibbs TT and Farb DH (1991) Pregnenolone sulfate: A positive allosteric modulator at the NMDA receptor. Mol Pharmacol 40:333-336.
40. Yaghoubi N, Malayev A, Russek SJ, Gibbs TT and Farb DH (1998) Neurosteroid modulation of recombinant ionotropic glutamate receptors. Brain Res 803:153-160.
41. Young AB, Greenamyre JT, Hollingsworth Z, Albin R, D'Amato C, Shoulson I and Penney JB (1988) NMDA receptor losses in putamen from patients with Huntington's disease. Science (Wash DC) 241:981-983.